Trimethylammonium

Trimethylammonium

SCHEMBL5423733

Br.Br.CN(C)C.CN(C)C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108291911-A REAGENT AND METHOD FOR MEASURING THROMBIN-ANTITHROMBIN COMPLEX 美迪恩斯生命科技株式会社 2018-07-17 CN claimed
US-5709976-A Coated papers XEROX CORPORATION (US) 1998-01-20 US claimed
US-12582612-B2 Pharmaceutical composition of Siglec-binding agents CYTODIGM, INC. (US) 2026-03-24 US disclosed
US-12569441-B2 Microparticles and nanoparticles having negative surface charges CYTODIGM, INC. (US) 2026-03-10 US disclosed
US-20240358653-A1 NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND CYTODIGM, INC. 2024-10-31 US disclosed
US-12070508-B2 Microparticles and nanoparticles having sulfate groups on the surface CYTODIGM, INC. (US) 2024-08-27 US disclosed
US-20240139141-A1 NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME RHNANOPHARMA (US) 2024-05-02 US disclosed
EP-4351520-A1 NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND CYTODIGM, INC. (US) 2024-04-17 EP disclosed
US-20240041770-A1 MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES CYTODIGM INC (US) 2024-02-08 US disclosed
US-11819488-B2 Nanosuspensions of salsalate and methods of using the same RHNANOPHARMA (US) 2023-11-21 US disclosed
US-11814408-B2 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof NICOX OPHTHALMICS, INC. (US) 2023-11-14 US disclosed
WO-2012107765-A2 PARTICLE FORMULATION KUECEPT LTD (GB) 2012-08-16 WO disclosed
US-20070290384-A1 Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof CABOT CORPORATION (US) 2007-12-20 US disclosed
US-20070178163-A1 Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof CABOT CORPORATION (US) 2007-08-02 US disclosed
US-20010044012-A1 Transparent substrate between a hydrophilic ink receiving layer and a colored hydrophobic luminescent layer; creating photographic quality prints XEROX CORPORATION 2001-11-22 US disclosed
US-6319591-B1 Ink jet recording substrates XEROX CORPORATION 2001-11-20 US disclosed
US-6210816-B1 Translucent xerographic recording substrates XEROX CORPORATION 2001-04-03 US disclosed
US-5714270-A Multifunctional recording sheets XEROX CORPORATION (US) 1998-02-03 US disclosed
US-5709976-A Coated papers XEROX CORPORATION (US) 1998-01-20 US disclosed
US-5672424-A Ink jet transparencies XEROX CORPORATION (US) 1997-09-30 US disclosed